FoodNavigator28d
Is this GLP-1.2? New generation of weight-loss drugs moving in
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With the potential to significantly change consumer eating habits, they are ...
Business Insider7d
Opko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptide
OPKO Health (OPK) and Entera Bio (ENTX) entered into a collaboration and license agreement to advance into the clinic the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet ...
Science Daily29d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Relative effects of genetically proxied glucagon‐like peptide‐1 receptor agonism on muscle and fat mass: A Mendelian randomization study. Diabetes, Obesity and Metabolism , 2025; DOI: 10.1111 ...
Rolling Out16d
9 ways peptides are revolutionizing modern medicine
Insulin itself is a peptide hormone, and newer peptide analogs have transformed diabetes management. Beyond insulin, glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized treatment ...
Yahoo Finance14d
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations
CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735. CordenPharma provides large-scale ...
MarketWatch27d
Why this newly public biotech could become a force in obesity treatments
as well as an oral peptide delivery technology, according to Evercore ISI analysts. Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.